Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines
2 Emergent BioSolutions Faces Lawsuits Related to Vaccine Troubles
3 Can Emergent BioSolutions Recover From Its Recent Blunders?
4 Emergent BioSolutions wins extension on smallpox vaccine deal
5 SHAREHOLDER ALERT: Emergent BioSolutions Inc. (EBS) Officers and Directors Under Investigation for Possible False Statements and Insider Trading
6 Here's what Wall Street expects from Emergent BioSolutions's earnings report
7 Emergent BioSolutions rises after announcing contract term extension by HHS
8 Emergent's new opioid awareness campaign taps NFL's Darren Waller to tackle overdose stigma
9 More J&J Vaccine Substance Made by Emergent Is Released by FDA
10 Johnson & Johnson eyes $2.5B in COVID vaccine sales as key immunology, oncology meds trounce expectations
11 Emergent BioSolutions Faces Shareholder Lawsuit from Illinois Safety Pension Fund
12 Analysts Estimate Emergent Biosolutions (EBS) to Report a Decline in Earnings: What to Look Out for
13 Emergent Biosolutions Inc (EBS) gains 1.16% for July 23
14 Emergent Biosolutions Inc (EBS) gains 3.14% for July 15
15 The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines · BioBuzz
16 UPDATE: FDA Says Is Not Yet Ready To Include The Emergent Biosolutions Plant In Janssen EUA As An Authorized Manufacturing Plant
17 UPDATE 1-U.S. authorizes additional batch of J&J COVID-19 vaccine produced by Emergent
18 Emergent Biosolutions Inc (EBS) gains 2.00% for July 19
19 Emergent BioSolutions (EBS) to Release Quarterly Earnings on Thursday
20 Lincolnshire Police fund sues COVID-19 vaccine-maker Lincolnshire
21 Woes continue piling up for Emergent as manufacturer faces investor revolt, insider trading allegations
22 F.D.A. Releases Another Batch of Johnson & Johnson’s Vaccine
23 Chatham Capital Group, Inc. Buys Vanguard Real Estate Index Fund ETF, Addus HomeCare Corp
24 Emergent Under Fire for Insider Trading in Shareholder Lawsuits
25 Covid Vaccine Makers Are 'Tempting Targets' for Investor Suits
26 Coronavirus (COVID-19) Update: July 2, 2021 | FDA
27 How Johnson & Johnson's COVID Vaccine Is Making a Comeback
28 Tonix Pharmaceuticals will buy a Frederick R&D facility to speed COVID-19 vaccine development
29 Emergent BioSolutions Pauses Vaccine Manufacturing
30 A brief timeline of Emergent BioSolutions' Baltimore presence
31 Marburgvirus Infection Market Size and Driving Forces 2021-28 | Eisai Co Ltd, Emergent BioSolutions Inc – The Manomet Current
32 Aspen to start J&J COVID-19 vaccine supplies to South Africa from Monday
33 Emergent BioSolutions Executives Got Bonuses Despite COVID-19 Vaccine Stumbles : Shots
34 Insights on Plasma Fractionation Market: Facts, Figures and Trends 2020-2026 by Bharat Serums and Vaccines Limited, Bio Products Laboratory Ltd., Emergent Biosolutions Inc., Green Cross Corporation, Intas Pharmaceuticals Ltd., Kabafusion, and more | Aff
35 In wake of Emergent BioSolutions' vaccine problems, CEO's stock trades come into focus
36 Global Influenza Vaccine Market Analysis 2021 By Top Players – Novavax, Inc., Biodiem, Abbott, Emergent Biosolutions Inc., Seqirus – Murphy's Hockey Law
37 Emergent BioSolutions pauses manufacturing COVID-19 vaccines
38 How Emergent BioSolutions Put an ‘Extraordinary Burden’ on the U.S.’s Troubled Stockpile
39 Is The Worst Over For Emergent Biosolutions Stock?
40 Biodefense Market is Booming in Near Future with Speedy Growth, Key Players – Emergent Biosolutions Xoma Corporation – Murphy's Hockey Law
41 Emergent BioSolutions' plant behind the lost J&J vaccine batch hit with several FDA red flags last year: report
42 Emergent BioSolutions: Top Official Warned That Vaccine Plant Had to Be 'Monitored Closely`
43 Yellow Fever Market to Explore Excellent Growth in Future : Pfizer, Glaxosmithkline, Merck
44 Is There Any Hope Left for Emergent BioSolutions?
45 Prokarium Appoints Kristen Albright as Chief Executive Officer
46 How Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine Returns
47 Emergent BioSolutions says it can make 1 billion Covid vaccine doses annually
48 Emergent Biosolutions Stock Takes A Hit From Vaccine Mix-Up At Baltimore Plant
49 Anthrax Vaccines Market Size, CAGR | Key Players – Emergent BioSolutions, Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum – The Manomet Current
50 Vaccines Market Size, CAGR | Key Players – AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer, – The Manomet Current
51 Pay for CEO of Emergent BioSolutions, maker of COVID vaccine in Baltimore, increased 51% in 2020
52 U.S. Bet on Covid Vaccine Manufacturer Even as Problems Mounted
53 BT Investment Management Ltd B
54 Emergent BioSolutions CEO, founder head for the Hill as Congress probes production contracts, errors
55 Emergent's Baltimore plant flagged for quality control concerns last April, FDA report reveals
56 Emergent BioSolutions: Punished For Answering The Call To Immediate Action
57 Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the US Department of HHS to Support the Opportunity for Further Expansion of Manufacturing Capacity for J&J's COVID-19 V
58 EXCLUSIVE: US donation of almost 5.7-million Pfizer shots en route to SA
59 Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen's late-stage antibody hopeful
60 Some Covid vaccine made by Emergent BioSolutions to be distributed, while much will be discarded
61 A vaccine maker ruined 15 million doses. Its CEO sold $11 million of stock before that was public
62 April 29, 2021 Emergent BioSolutions Reports Financial Results for First Quarter 2021
63 Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ
64 SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
65 Opinion | A Vaccine Maker’s Investment: Emergent BioSolutions Responds
66 Maryland-based Novavax’s effort to vaccinate the world, from zero to not quite warp speed: ‘This takes time and expertise’
67 FDA Clears 10M Johnson & Johnson COVID Vaccine Doses From Baltimore’s Emergent BioSolutions
68 Officials review tax deal for Emergent BioSolutions drug manufacturing plant in DeWitt Township
69 Stocks making the biggest moves in the premarket: J&J, Emergent BioSolutions, Micron Technology & more
70 Why Emergent BioSolutions Stock Fell Today
71 Entwistle & Cappucci LLP Investigative Alert: Emergent BioSolutions Inc. (EBS)
72 J&J (JNJ) Raises 2021 Earnings Forecast as Quarter Beats Expectations
73 Emergent BioSolutions CEO: ‘Confrontational’ coverage of vaccine maker puts a target on ‘people doing good’ | COMMENTARY
74 CDC advisers hold off on Covid booster shot call
75 SHAREHOLDER ALERT: Robbins LLP Announces That Emergent BioSolutions Inc. (EBS) is Being Sued for Misleading Shareholders
76 Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use
77 Why Emergent BioSolutions Stock Dropped 30% in April
78 Investor sues Emergent BioSolutions for alleged fraud, seeks class action
79 CEO at troubled vaccine plant received 51 percent compensation boost in 2020
80 A Who's Who of Revolving-Door Influence at Emergent BioSolutions
81 Here’s Why Emergent BioSolutions (EBS) Became One of Carillon’s Worst Securities
82 Johnson & Johnson COVID-19 vaccine to be made in Baltimore
83 Why Emergent BioSolutions Stock Is Sliding Today
84 Harbor Investment Advisory, Llc Buys FedEx Corp, Roblox Corp, Uber Technologies Inc, Sells iShares TIPS Bond
85 $EBS FDA Poised To Clear Another Batch Of J&J Vaccine Made From Emergent Manufacturing Plant In Baltimore Today
86 Emergent BioSolutions Stock News: Berger Montague Announces Investigation Into Securities Fraud Allegations Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021
87 Olympics: Biles ends event, citing mental health
88 Naloxone Spray Market: Growth, Revenue, Business Outlook & Forecast 2021-2031 | Medline Industries, Inc.; Emergent BioSolutions, Pfizer, and Teva Pharmaceuticals Industries Ltd. and others. – The Manomet Current
89 J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses
90 Emergent BioSolutions Inc (EBS) Q1 2021 Earnings Call Transcript
91 Emergent Biosolutions Seeks New Talent to Support Global COVID-19 Vaccination Push, Expanding Project Portfolio · BioBuzz
92 Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™
93 Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020
94 Emergent BioSolutions, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit
95 HAGENS BERMAN Encourages Emergent BioSolutions (EBS)
96 Biden admin probes risk of low-level contamination in vaccines made at troubled plant
97 President Joe Biden’s Visit To Emergent BioSolutions’ Baltimore Lab Canceled
98 FDA asks Emergent plant to pause manufacturing while it investigates botched Covid vaccines
99 Lobby Wrap: Health stays hot on lobbying circuit
100 Global Bioterrorism Market has Historical and forecast size with Broader Overview Analysis Forecast From 2021-2027 – The Manomet Current